治験管理システム (CTMS) の世界市場予測 2022年：Webホステッド・オンプレミス・クラウドベース
Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022
|出版日||ページ情報||英文 266 Pages
|治験管理システム (CTMS) の世界市場予測 2022年：Webホステッド・オンプレミス・クラウドベース Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022|
|出版日: 2018年01月18日||ページ情報: 英文 266 Pages||
世界の治験管理システム (CTMS) 市場規模、2017年から2022年にかけて12.6%のCAGR (年間複合成長率) で推移し、2022年までに10億6,560万米ドルに達すると予測されています。バイオ製薬会社とCRO（開発業務受託機関）の間での参加数の増加、進行中の治験数の増加、治験を支援する政府の財源および補助金の増加、先進CTMSソリューションの利用拡大、および顧客ベースのCTMSソリューションの成長といった要因は、CTMS市場の成長を促進しています。
当レポートでは、世界の治験管理システム (CTMS) 市場の現状と見通しについて調査分析し、市場の概要、市場成長への影響因子および市場機会の分析、エンドユーザー・デリバリー形態・コンポーネント・タイプ地域など各種区分別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルをまとめています。
"The clinical trial management system (CTMS) market is projected to grow at a CAGR of 12.6% during the forecast period"
The global CTMS market is projected to reach USD 1,065.6 million by 2022 from USD 590.0 million in 2017, at a CAGR of 12.6%. The major factors driving the growth of the CTMS market include the increasing partnerships between biopharma companies and CROs, rising number of ongoing clinical trials, rising government funding & grants to support clinical trials, availability of advanced CTMS solutions, and growing customer base for CTMS solutions. However, the major market restraints are limited awareness among researchers about the advantages of CTMS solutions and budget constraints faced by the emerging countries.
On the basis of delivery mode, the global CTMS market is segmented into web-based (on-demand), licensed enterprise (on premise), and cloud-based (SaaS) segments. The cloud-based (SaaS) segment is estimated to witness the highest growth during the forecast period, primarily due to the rising adoption of cloud-based solutions in medical research studies owing to various benefits offered by them such as low cost, high security, privacy, and easy accessibility from any device.
On the basis of component, the CTMS market is segmented into software and services. The software segment is expected to have the largest share of the market. This is mainly attributed to the fierce competition in the pharmaceutical industry to introduce cost-effective novel drugs in the market, increased adoption of CTMS due to advantages provided by the same among various end users, and increasing number of clinical trials.
Geographically, the CTMS market is segmented into North America, Europe, Asia Pacific (APAC), and the rest of the world. The APAC market is expected to register the highest growth rate during the forecast period. Increasing government funding to support clinical trials, the presence of less stringent regulatory guidelines as compared to developed nations, a large patient base, faster rate of patient recruitment for clinical trials than mature nations, low operating costs for conducting clinical trials, shortage of trial volunteers in Europe and North America, and the growing number of pharmaceutical companies and CROs are fueling the growth of the APAC CTMS market.
The major players in the market included are: Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), and IBM (US).
This report studies the CTMS market based on type, delivery mode, component, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
This report focuses on various levels of analysis-industry trends, market ranking of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the CTMS market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
Top 15 companies analyzed for this studies are - Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), IBM (US), DATATRAK (US), Veeva Systems (US), DSG (US), MasterControl (US), ERT (US), Forte Research Systems (US), MedNet Solutions (US), ArisGlobal (US), and DZS Software Solutions (US).
*Details on MarketsandMarkets view, Introduction, Product & Services, New Developments might not be captured in case of unlisted companies.